Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82467866 | 8246786 | 6 | F | 20121022 | 20111116 | 20121029 | EXP | PHEH2011US08280 | SANDOZ | 0.00 | M | Y | 0.00000 | 20121029 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82467866 | 8246786 | 1 | PS | TASIGNA | 1 | ORAL | 150 MG, QID | U | F0005A | 0 | 150 | MG | QID | ||||||
| 82467866 | 8246786 | 2 | SS | TASIGNA | 1 | ORAL | 300 MG, BID | U | UNKNOWN | 0 | 300 | MG | BID | ||||||
| 82467866 | 8246786 | 3 | SS | PROMETHAZINE | 1 | 25 MG, Q5H | U | 84176 | 25 | MG | Q5H | ||||||||
| 82467866 | 8246786 | 4 | C | INSPRA | 1 | 50 MG, BID | U | 0 | 50 | MG | BID | ||||||||
| 82467866 | 8246786 | 5 | C | NOVOLOG | 1 | 250-300 UNITS PER DAY | U | 0 | |||||||||||
| 82467866 | 8246786 | 6 | C | CATAPRES-TTS-3 | 2 | UNK UKN, UNK | U | 0 | Patch | ||||||||||
| 82467866 | 8246786 | 7 | C | NITROGLYCERIN | 1 | 4 MG, PRN | U | 0 | 4 | MG | |||||||||
| 82467866 | 8246786 | 8 | C | ATIVAN | 1 | 1 MG, AS NEEDED | U | 0 | 1 | MG | |||||||||
| 82467866 | 8246786 | 9 | C | PERCOCET | 1 | UNK UKN, UNK | U | 0 | |||||||||||
| 82467866 | 8246786 | 10 | C | RANITIDINE HYDROCHLORIDE | 1 | 1 MG, AS NEEDED | U | 0 | 1 | MG | |||||||||
| 82467866 | 8246786 | 11 | C | LOPROX | 1 | UNK UKN, UNK | U | 0 | Cream |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 82467866 | 8246786 | 1 | Chronic myeloid leukaemia |
| 82467866 | 8246786 | 3 | Nausea |
| 82467866 | 8246786 | 7 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 82467866 | 8246786 | OT |
| 82467866 | 8246786 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 82467866 | 8246786 | Blood pressure increased | |
| 82467866 | 8246786 | Chest discomfort | |
| 82467866 | 8246786 | Chest pain | |
| 82467866 | 8246786 | Coronary artery occlusion | |
| 82467866 | 8246786 | Cough | |
| 82467866 | 8246786 | Diabetes mellitus | |
| 82467866 | 8246786 | Diarrhoea | |
| 82467866 | 8246786 | Dizziness | |
| 82467866 | 8246786 | Gastric disorder | |
| 82467866 | 8246786 | Haemorrhage | |
| 82467866 | 8246786 | Headache | |
| 82467866 | 8246786 | Herpes zoster | |
| 82467866 | 8246786 | Hypertriglyceridaemia | |
| 82467866 | 8246786 | Hypopnoea | |
| 82467866 | 8246786 | Malaise | |
| 82467866 | 8246786 | Nausea | |
| 82467866 | 8246786 | Palpitations | |
| 82467866 | 8246786 | Pruritus | |
| 82467866 | 8246786 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 82467866 | 8246786 | 1 | 20120420 | 0 |